Part Two of a conversation on US healthcare in our “post-pandemic” moment: the legacy challenges, the current tragic clashes around untreated mental health episodes in public spaces, as well as the current wave of innovation and opportunity that might, if leveraged and supported, help us move towards equitable, quality healthcare.
Kim Langenhahn
Director, US Health
Kim draws on more than 15 years of consulting, operational, and startup experience in the domestic and international health and nonprofit sectors to help organizations navigate complex issues, operate more effectively, and deliver greater impact.
During the course of her career, Kim has helped numerous healthcare organizations tackle a variety of strategic challenges such as scaling Terrapin Pharmacy’s remote medication adherence system, launching a MENA-focused healthcare incubator, devising system-wide strategy for the Saudi Arabian Ministry of Health as part of PwC’s consulting practice, and developing a market forecast for a pharmaceutical company alongside her L.E.K. Consulting colleagues. She is also the Cofounder of a small social enterprise that she runs with her family.
Kim earned a Master of Business Administration and a Master of Public Policy from the University of Chicago as well as a Master of Science in Quantitative Management and a Bachelor of Arts from Duke University. An avid traveler, reader, bread baker, ice cream churner, and (aspiring) cheese maker, she also enjoys helping her husband tend to their rooftop garden and vermiculture operation. She currently resides in Washington, D.C.
Posts by Kim Langenhahn
Join us for a far-reaching conversation about US healthcare and its many facets, angles, deficits—but also opportunities and bright spots in the quest to provide equitable, quality healthcare more broadly to people living in the United States. In Part One, we look at the “end of the pandemic,” and some general facts, figures, and frustrations about US healthcare as it currently is delivered.
In 2023. Medicaid lies in a tug of war between the redetermination process, expanded maternal coverage, and the ongoing struggle for health equity. The stakes for too many, particularly Black and Hispanic expectant mothers, is unacceptably high.